drugset / Trial / NCT03736369
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of study is to confirm the efficacy of DWP14012 Xmg, Once daily, compared to esomeprazole 40mg in patients with erosive gastroesophageal reflux disease.
Timeline
- Start
- 2018-12-13
- Primary completion
- 2019-08-07
- Completion
- 2019-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABEPRAZAN | Small molecule | 40 mg | Oral |
| Comparator | Esomeprazole | Small molecule | 40 mg | Oral |